THE LIGHTHOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: J82060 | SOUTHSEA, PO5 1AT
Showing results 151-200 of 627
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone furoate | 262 | 15.7K | £1.5K | +95.9% ▲ |
| Insulin aspart | 261 | 1,661 | £11.4K | -31.5% ▼ |
| 257 | 3,258 | £1.1K | +3.0% ▲ | |
| Docusate sodium | 256 | 26.5K | £1.8K | -30.9% ▼ |
| Methylphenidate hydrochloride | 253 | 10.7K | £9.6K | -2.0% ▼ |
| Sitagliptin | 253 | 10.6K | £736 | -35.1% ▼ |
| Diclofenac diethyl | 252 | 28.5K | £1.9K | -29.0% ▼ |
| 247 | 4,057 | £4.2K | +1,247.6% ▲ | |
| Estriol | 246 | 4,617 | £2.1K | +15.6% ▲ |
| 245 | 2,586 | £2.9K | +646.7% ▲ | |
| Betamethasone valerate | 237 | 19.7K | £1.2K | -38.4% ▼ |
| Aripiprazole | 234 | 8,209 | £1.4K | -8.0% ▼ |
| Semaglutide | 231 | 4,247 | £20.8K | -4.1% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 229 | 29.6K | £2.5K | +1.3% vs avg |
| Fluticasone furoate/vilanterol | 224 | 300 | £7.0K | +44.7% ▲ |
| Vitamin B compound | 224 | 10.1K | £312 | +60.8% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 221 | 292 | £4.1K | +94.8% ▲ |
| Trimethoprim | 220 | 6,682 | £508 | +7.7% ▲ |
| Hydroxychloroquine sulfate | 220 | 7,328 | £342 | +13.6% ▲ |
| Baclofen | 219 | 49.9K | £609 | +9.3% ▲ |
| Nortriptyline | 213 | 14.8K | £521 | +46.4% ▲ |
| Sulfasalazine | 210 | 44.9K | £10.8K | +61.3% ▲ |
| Clobetasone butyrate | 209 | 11.6K | £2.2K | +2.4% ▲ |
| Tadalafil | 207 | 3,200 | £548 | +21.7% ▲ |
| 204 | 16.3K | £1.5K | +332.1% ▲ | |
| Insulin glargine | 201 | 1,344 | £9.8K | -29.2% ▼ |
| Alfacalcidol | 199 | 8,030 | £1.2K | +60.9% ▲ |
| Progesterone | 196 | 17.8K | £3.5K | -53.2% ▼ |
| Oxybutynin | 193 | 10.2K | £2.4K | +1.3% vs avg |
| Co-dydramol (Dihydrocodeine/paracetamol) | 190 | 25.6K | £1.4K | +5.7% ▲ |
| Clarithromycin | 189 | 3,891 | £724 | -23.0% ▼ |
| 187 | 2,783 | £1.5K | +477.9% ▲ | |
| Prochlorperazine maleate | 184 | 7,646 | £506 | -9.0% ▼ |
| Nifedipine | 178 | 8,721 | £2.8K | -5.0% ▼ |
| Diclofenac sodium | 178 | 12.5K | £719 | +250.6% ▲ |
| Lisinopril | 176 | 11.4K | £251 | -83.9% ▼ |
| Haloperidol | 176 | 3,289 | £27.1K | +269.5% ▲ |
| Vortioxetine | 176 | 2,142 | £2.0K | +153.6% ▲ |
| Topiramate | 176 | 9,813 | £1.2K | -1.0% vs avg |
| Lacidipine | 174 | 12.8K | £1.0K | +45.6% ▲ |
| 173 | 2,495 | £4.2K | +525.3% ▲ | |
| Calcipotriol | 171 | 12.5K | £6.1K | +0.4% vs avg |
| 169 | 81.4K | £616 | +85.3% ▲ | |
| Donepezil hydrochloride | 167 | 4,480 | £166 | -45.9% ▼ |
| Clobetasol propionate | 167 | 11.7K | £1.3K | +22.4% ▲ |
| Zolpidem tartrate | 166 | 2,686 | £120 | +84.2% ▲ |
| Urea | 165 | 75.7K | £2.3K | +146.9% ▲ |
| Insulin degludec | 163 | 869 | £10.0K | +48.3% ▲ |
| Medroxyprogesterone acetate | 163 | 163 | £917 | +35.0% ▲ |
| 162 | 2,369 | £1.7K | +311.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.